Gastric Motility Disorder Drugs Market The global gastric motility disorder drugs market is undergoing significant evolution,…
Continue ReadingTag: Gastric
Health expenditure trajectory and gastric cancer incidence in the National Health Insurance Senior Cohort: a nested case-control study | BMC Health Services Research
Balakrishnan M, George R, Sharma A, et al. Changing trends in stomach cancer throughout the world.…
Continue Reading
Progress Made for Gastric Cancer with FDA Approval of Tevimbra
The FDA has approved Tevimbra (tislelizumab-jsgr) for a second indication: in combination with platinum and fluoropyrimidine-based…
Continue Reading
Research: Gastric Bypass Advised for Severely Obese Patients
Gastric bypass is the most clinically and cost effective form of interventional surgery for people living…
Continue Reading
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer | BMC Gastroenterology
The GENERATE study provides a detailed description of patient characteristics, treatment patterns, HCRU and survival outcomes…
Continue Reading
Biomarkers used in the diagnosis and prognosis of gastric cancer in young patients: A scientometric analysis
SYSTEMATIC REVIEW article Front. Med. Sec. Gastroenterology Volume 12 – 2025 | doi: 10.3389/fmed.2025.1586742 This article…
Continue Reading